ImmusanT reports data on novel celiac disease diagnostic approach
ImmusanT, Inc., a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.
Link:
ImmusanT reports data on novel celiac disease diagnostic approach
May 10, 2017 · by · in Nutritional News · Tags: diet, effects, gluten-exposure, hla, nexvax2, nutrition, oncalldietitian.com, the-effects, vaccine-intended
